Technical Analysis for AKAOQ - Achaogen Inc

Grade Last Price % Change Price Change
grade F 0.011 -16.03% -0.0021
AKAOQ closed down 16.03 percent on Friday, August 23, 2019, on 29 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AKAOQ trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Crossed Above 20 DMA Bullish -16.03%
Wide Bands Range Expansion -16.03%
Lower Bollinger Band Touch Weakness -16.03%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%

Older signals for AKAOQ ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Achaogen, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibacterial agents for multi-drug resistant (MDR) gram-negative infections in the United States. The company is principally developing plazomicin for the treatment of serious bacterial infections due to MDR enterobacteriaceae comprising carbapenem-resistant enterobacteriaceae. It is also involved in the development of antibacterial candidate C-Scape, an orally-administered combination of clavulanate and ceftibuten, which targets serious bacterial infections due to expanded spectrum beta-lactamases producing enterobacteriaceae. The company has license and collaboration agreements with Thermo Fisher Scientific, Inc. to develop and commercialize an assay to support plazomicin; Crystal Biosciences, Inc. to discover monoclonal antibodies against multiple targets; Ionis Pharmaceuticals, Inc. for certain patents relating to aminoglycoside antibacterial compounds and related know-how to develop and commercialize certain novel aminoglycoside antibacterial compounds; and Hovione Limited manufacture the active pharmaceutical ingredient for plazomicin. The company was incorporated in 2002 and is based in South San Francisco, California. On April 15, 2019, Achaogen, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Medicine Biopharmaceutical Drugs Infectious Diseases U.S. Bankruptcy Court Antibodies U.S. Bankruptcy Court For The District Of Delaware Antibiotic Multiple Drug Resistance
Is AKAOQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 5.48
52 Week Low 0.006
Average Volume 283,429
200-Day Moving Average 0.7064
50-Day Moving Average 0.0155
20-Day Moving Average 0.0127
10-Day Moving Average 0.0119
Average True Range 0.0051
ADX 29.07
+DI 13.1837
-DI 16.5498
Chandelier Exit (Long, 3 ATRs ) 0.002
Chandelier Exit (Short, 3 ATRs ) 0.0213
Upper Bollinger Band 0.0165
Lower Bollinger Band 0.0089
Percent B (%b) 0.28
BandWidth 59.84252
MACD Line -0.0027
MACD Signal Line -0.0033
MACD Histogram 0.0006
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0179
Resistance 3 (R3) 0.0177 0.0151 0.0168
Resistance 2 (R2) 0.0151 0.0134 0.0153 0.0164
Resistance 1 (R1) 0.0131 0.0123 0.0141 0.0133 0.0160
Pivot Point 0.0105 0.0105 0.0111 0.0107 0.0105
Support 1 (S1) 0.0085 0.0088 0.0095 0.0087 0.0060
Support 2 (S2) 0.0059 0.0077 0.0061 0.0056
Support 3 (S3) 0.0039 0.0059 0.0053
Support 4 (S4) 0.0041